Related Experiment Video
Updated: Jul 13, 2026

07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
[Gastrointestinal stromal tumors: conceptual evolution].
Ismael B Fonseca1, Luis S Spitale, Luis Gramática
1II Cátedra de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Hospital de Urgencias.
Summary
Gastrointestinal stromal tumors (GISTs) are rare digestive tract neoplasms. This paper analyzes the historical evolution and conceptual understanding of GISTs, from early descriptions to current insights.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Context:
- Gastrointestinal stromal tumors (GISTs) are the most common nonepithelial neoplasms of the digestive tract, primarily affecting the stomach and small bowel.
- These tumors can occur throughout the gastrointestinal tract and associated tissues.
- Historically, GISTs have been described under various terms, reflecting evolving understanding of their origin and behavior.
Purpose:
- To analyze the historical evolution of GIST classification and conceptualization.
- To review the changing terminology and proposed origins of GISTs.
- To provide an overview of the historical understanding of GISTs.
Summary:
- GISTs represent 1-2% of digestive tract neoplasms, originating in the stomach and small bowel but also found elsewhere.
- Early terms like leiomyoblastoma and smooth muscle tumor of uncertain malignant potential (SMTUMP) were used due to diagnostic challenges.
- The term gastrointestinal stromal tumor (GIST) was coined in 1983, with later research suggesting origins from interstitial Cajal cells or the myenteric nervous system.
Impact:
- Understanding the historical context is crucial for appreciating the diagnostic and therapeutic advancements in GIST management.
- The evolving terminology highlights the complexity and ongoing research into GIST origins and classification.
- This historical analysis provides a foundation for comprehending current research and clinical approaches to GISTs.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...